Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
March 31, 2015
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
Conditions
BurnsInfection
Interventions
DRUG
Tobramycin
Trial Locations (1)
M4N3M5
Sunnybrook Health Sciences Centre, Toronto
All Listed Sponsors
lead
Sandra Walker
OTHER
NCT02269969 - Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study | Biotech Hunter | Biotech Hunter